Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Strand Michael B.Chief Revenue Officer | Tax withholding | F | $1,349 4,216 sh | Apr 13, 2026 |
| 9 | Hoops RobinCHIEF FINANCIAL OFFICER | Grant or award | A | — 500.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Zhang Yi WenDirector | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Panzara Michael A.Director | Grant or award | A | — 28.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Bolton JeffreyDirector | Grant or award | A | $37K 2,680 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Krause Allyson G.General Counsel | Tax withholding | F | $6,646 20.8K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Mulroy BrianChief Financial Officer | Tax withholding | F | $47K 3,941 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Sankarlingam VelchamyPres. of Engineering & Product | Option exercise | M | — 4,845 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Teng Song-YuanDirector, Chief Executive Officer (Asia) | Grant or award | A | — 600.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Kosacz BarbaraDirector | Grant or award | A | — 28.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Dreiling Richard WDirector | Grant or award | A | $27K 641 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Church KevinCHIEF SCIENTIFIC OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 99.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Wirfel MichelleEVP, Chief Operating Officer | Tax withholding | F | $2,831 154 sh | Apr 13, 2026 traded Apr 12, 2026 |
| 9 | Solomon Lance I.Chief Product Officer | Tax withholding | F | $3,414 10.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Yellin Jonathan DEVP AND GENERAL COUNSEL | Grant or award | A | — 1,396 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 8 | O'Connor CaseyChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $185K 60.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 8 | Moat RossCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $80K 1,703 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 7 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 6 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $59K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec | Open-market sale · 10b5-1 plan | SELL | $7,970 693 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 5 | Shetty Reshma P.Director, See remarks, 10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Canton Barry10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $384K 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Perducat CyrilSVP, Chief Technology Officer | Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Erlinger Joseph M.President, McDonald's USA | Option exercise · 10b5-1 plan | M | — 2,626 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 42.4K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 2 | Yuan Eric S.Director, Chief Executive Officer | Grant or award | A | — 561.6K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 1 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,200 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 1 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Open-market sale · 10b5-1 plan | SELL | $39K 500 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $35K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $86K 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Chang MichelleChief Financial Officer | Option exercise · 10b5-1 plan | M | — 0 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $35K 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 6,613 sh | Apr 13, 2026 traded Apr 13, 2026 |
| 0 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |